Stimulating early growth in healthcare and AI.

Dew Capital backs exceptional founders building AI and healthcare companies across North America and Europe.

Portfolio 12

About

  • Led by Dylan de WaartInvesting in healthcare and AI
  • Founder turned investorCo-founded Recover
    Y Combinator W21
  • Harvard UniversityDegree in Economics and Computer Science
  • McKinsey & CompanyOversaw COVID-19 surge planning for 50+ hospitals during the pandemic
  • Y CombinatorMentored by Michael Seibel
  • RecoverProvided free addiction care to low-income Americans
  • Biotech BoosterAdvisor-at-large, Dutch government biotech commercialization program
  • Extend CareRe-engineering how chronic care is delivered and reimbursed

Dew Capital is led by Dylan de Waart. He is a founder turned investor who backs exceptional founders building AI and healthcare companies across North America and Europe.

Dylan studied Economics and Computer Science at Harvard University before starting his career as a management consultant at McKinsey & Company in San Francisco. During the pandemic, his focus shifted to healthcare, eventually overseeing the Covid surge preparedness of over 50 hospitals nationwide. He left McKinsey to co-found Recover and tackle a different epidemic: the opioid crisis. He joined Y Combinator's Winter 2021 batch and was mentored by Michael Seibel (the CEO of Twitch and YC) as he launched Recover to make addiction care more effective, accessible, and affordable through partnerships with local governments.

As an active member of the Y Combinator community, Dylan started to invest in other YC companies before expanding to include the European startup ecosystem as well, often leveraging his Harvard and McKinsey alumni networks to meet driven and innovative founders. He also serves as an advisor-at-large coaching startups in the Dutch government's biotech commercialization program. Alongside investing, he continues to build at the intersection of healthcare and artificial intelligence.

Leveraging the Harvard, McKinsey, and Y Combinator communities to back exceptional founders building AI and healthcare companies across North America and Europe.